The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: Air hunger, anxiety and fear

被引:34
作者
Morelot-Panzini, Capucine [1 ,2 ]
Perez, Thierry [3 ,4 ]
Sedkaoui, Kamila [5 ]
de Bock, Elodie [6 ]
Aguilaniu, Bernard [7 ]
Devillier, Philippe [8 ]
Pignier, Christophe [9 ]
Arnould, Benoit [6 ]
Bruneteau, Gaelle [10 ,11 ]
Similowski, Thomas [1 ,2 ]
机构
[1] Sorbonne Univ, INSERM, Neurophysiol Resp Expt & Clin UMRS1158, F-75005 Paris, France
[2] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Pneumol & Reanimat Med, Dept R3S, F-75013 Paris, France
[3] CHU Lille, Clin Malad Resp, F-59000 Lille, France
[4] Inst Pasteur, Ctr Infect & Immun Lille, INSERM, U1019,CNRS,UMR 8204, F-59000 Lille, France
[5] Ctr Hosp Reg & Univ Toulouse, Hop Larrey, Serv Pneumol, Toulouse, France
[6] Mapi, Patient Ctr Outcomes, Lyon, France
[7] Univ Grenoble Alpes, Grenoble, France
[8] Hop Foch, UPRES EA220, Suresnes, France
[9] Pierre Fabre Medicament, Castres, France
[10] Sorbonne Univ, Inst Cerveau & Moelle Epiniere, INSERM, U1127,ICM,CNRS,UMR 7225, F-75013 Paris, France
[11] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Ctr Referent SLA, F-75013 Paris, France
关键词
Dyspnoea; Amyotrophic lateral sclerosis; Chronic respiratory failure; Noninvasive ventilation; Multidimensional dyspnea profile; Patient-reported outcomes; PALLIATIVE CARE; MANAGEMENT; BREATHLESSNESS; RELIABILITY; DEPRESSION; SCALES; LIFE;
D O I
10.1016/j.rmed.2018.10.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder leading to chronic respiratory failure. Few studies have investigated ALS-related dyspnoea, and none have characterised the emotional distress it inflicts. We hypothesised that ALS-related dyspnoea has a strong affective component that relates to quality of life. Methods: This prospective, observational study was conducted in 41 ALS patients > 18 with chronic respiratory failure and an indication for noninvasive ventilation (NIV). Dyspnoea was assessed using the Multidimensional Dyspnea Profile (MDP) at baseline and 1 month after NIV initiation. Correlations between scores evaluating the sensory and affective dimensions of dyspnoea and other patient-reported outcomes and pulmonary function tests were analysed. Results: Dyspnoea was described as intense (median [IQR] score on a 0-10 scale: 6.5 [4.0-7.5]). The sensory dimension of dyspnoea was polymorphic, but "air hunger" was the most common (48.8%) and the most intense (6 [4-8]) sensory descriptor. In the affective domain, most patients rated "anxious" (85.4%) and "afraid" (60.9%) above 0. The MDP affective dimension correlated significantly with other patient-reported outcomes, with the strongest correlation being between MDP "anxious" and the anxiety component of the Hospital Anxiety Depression Scale (Pearson's R = 0.70). One month after initiation of NIV, dyspnoea during unassisted breathing was described in virtually the same terms, particularly the affective dimension. Discussion: ALS-related dyspnoea is intense and fear-provoking, persists during unassisted breathing between NIV sessions, and significantly impacts health-related quality of life. This study highlights the need for increased awareness of and research into ALS-related dyspnoea.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 38 条
  • [1] Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research
    Banzett, Robert B.
    O'Donnell, Carl R.
    Guilfoyle, Tegan E.
    Parshall, Mark B.
    Schwartzstein, Richard M.
    Meek, Paula M.
    Gracely, Richard H.
    Lansing, Robert W.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (06) : 1681 - 1691
  • [2] Effective management of breathlessness: a review of potential human rights issues
    Basoglu, Metin
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
  • [3] Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead
    Blackhall, Leslie J.
    [J]. MUSCLE & NERVE, 2012, 45 (03) : 311 - 318
  • [4] El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
    Brooks, BR
    Miller, RG
    Swash, M
    Munsat, TL
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05): : 293 - 299
  • [5] Invisible suffering: breathlessness in and beyond the clinic
    Carel, Havi
    Macnaughton, Jane
    Dodd, James
    [J]. LANCET RESPIRATORY MEDICINE, 2015, 3 (04) : 278 - 279
  • [6] Carvalho Tatiana Lins, 2016, Trends Psychiatry Psychother., V38, P1, DOI 10.1590/2237-6089-2015-0030
  • [7] Morphine in the management of dyspnoea in ALS. A pilot study
    Clemens, K. E.
    Klaschik, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (05) : 445 - 450
  • [8] Coordinated care affects hospitalization and prognosis in amyotrophic lateral sclerosis: a cohort study
    Cordesse, Valerie
    Sidorok, Florence
    Schimmel, Priscilla
    Holstein, Josiane
    Meininger, Vincent
    [J]. BMC HEALTH SERVICES RESEARCH, 2015, 15
  • [9] The active identification and management of chronic refractory breathlessness is a human right
    Currow, David C.
    Abernethy, Amy P.
    Ko, Danielle N.
    [J]. THORAX, 2014, 69 (04) : 393 - 394
  • [10] Management and treatment of respiratory failure associated with amyotrophic lateral schlerosis.
    Danel-Brunaud, V
    Perez, T
    Just, N
    [J]. REVUE NEUROLOGIQUE, 2005, 161 (04) : 480 - 485